Jan 28 (Reuters) - Conmed Q4 sales USD 373.198 million vs. IBES estimate USD 366.8 million.
Q4 pretax profit USD 29.253 million
Q4 income from operations USD 36.623 million
Q4 EPS USD 0.54
Q4 net income USD 16.739 million
outlook FY revenue USD 1,345-1,375 million
outlook FY adjusted EPS USD 4.3-4.45
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.